Citation 73614

MA,X: LEE,IS: CHAI,HB: ZAW,K: FARNSWORTH,NR: SOEJARTO,DD: CORDELL,GA: PEZZUTO,JM: KINGHORN,AD:. (1994). CYTOTOXIC CLERODANE DITERPENES FROM POLYALTHIA BARNESII.. 37(6)

Citation Details

Title	CYTOTOXIC CLERODANE DITERPENES FROM POLYALTHIA BARNESII.
Authors	MA,X: LEE,IS: CHAI,HB: ZAW,K: FARNSWORTH,NR: SOEJARTO,DD: CORDELL,GA: PEZZUTO,JM: KINGHORN,AD:
Year	1994
Volume	37
Issue	6

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Polyalthia barnesii (ANNONACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	None
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	WEAK ACTIVITY
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	WEAK ACTIVITY
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-3-CIS-13(14)-DIEN-15-16-OLIDE,16-ALPHA-HYDROXY:	ACTIVE
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	None
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLERODA-4(18)-CIS-13(14)-15-16-OLIDE,3-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
28	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	None
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	INACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	ACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEROD-CIS-13(14)-EN-15-16-OLIDE,4-BETA-16-ALPHA-DIHYDROXY:	WEAK ACTIVITY

Citation 73614

Citation Details

Summary

Organisms and Their Experiments (1)

Polyalthia barnesii (ANNONACEAE)

Show SPARQL Queries (1)

Query 1